chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: 3/3 10:00 AM ET mild fever (99.5), fatigue, mild headache, tenderness in arm at injection site; 3/3 10:00 AM ET mild fever (99.5), fatigue, mild headache, tenderness in arm at injection site; 12 hours post-injection symptoms started3/2 10:30 PM ET mild fever, chills3/3 1:00 AM ET mild fever (100.7), chills, pain/tenderness in arm at injection site; 12 hours post-injection symptoms started3/2 10:30 PM ET mild fever, chills3/3 1:00 AM ET mild fever (100.7), chills, pain/tenderness in arm at injection site; 12 hours post-injection symptoms started3/2 10:30 PM ET mild fever, chills3/3 1:00 AM ET mild fever (100.7), chills, pain/tenderness in arm at injection site; This is a spontaneous report from a contactable consumer (Patient). A 50-year-old male received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, on 02Mar2021 at 10:15 (at the age of 50-year-old), as dose 1, single in left arm for COVID-19 immunization at Workplace Clinic. The patient's medical history was reported as none. Patient had no allergies to medications, food, or other products. Concomitant medications within 2 weeks of vaccination were reported as none. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Mar2021 at 22:30, 12 hours and 15 minutes after first dose of vaccine, the patient experienced fever (100.7), chills, pain/tenderness in arm at injection site; all for a duration of 1 day 11 hours and 15 minutes. On 03Mar2021 at 22:30 fatigue, fever (99.5); and mild headache for 11 hours and 15 minutes. Patient received treatment for adverse events with Acetaminophen (Tylenol), recommended dosage. On 04Mar2021 at 9:45 AM, the patient had no fever, slight fatigue, no headache, and no arm pain. The patient underwent lab test and procedure which included SARS-CoV-2 test: positive on an unspecified date prior to vaccination; body temperature: 100.7 on 02Mar2021; 99.5 on 03Mar2021; and no fever on 04Mar2021. The clinical outcome of the event fatigue was resolving. The patient had COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of all other events was resolved on 04Mar2021 at 9:45 AM.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Coordination abnormal, Pyrexia
Clinical narrative: coordination was totally off; his temperature went to 99 and then it would go to 100 then back to 98 then 99; This is a spontaneous report from a contactable other health care professional. An 85-year-old male patient first dose of BNT162B2 (COMIRNATY, Solution for injection, lot/batch number was unknown), via an unspecified route of administration on 20Feb2021 as DOSE 1 SINGLE for COVID-19 immunisation. The patient's medical history included paralyzed on the right side, blind, and hard of hearing. The patient's concomitant medications were not reported. The patient ran a low grade temperature of 99. His coordination was totally off. So, she kept him in bed. She gave him Tylenol, and put a cold wash rag on his head. Now his temperature was going up and down from 98 to 99. His coordination was a lot better. He can actually stand up now and not lean back. This has concerned her because of the fever. One time it was 100. He has been eating excellent. He has not lost his appetite. He says he was in no pain. He got the shot on the 20Feb2021, and his fever just started two days ago 03Mar2021. He very seldom got fevers of 99. She did not want to do a safety report because she did not know if this was from the vaccine. The patient underwent lab test and procedure of body temperature on 03Mar2021 and resulted into 99 and then it would go to 100 then back to 98 then 99. Only got to 100, 1 or 2 times. The outcome of event low grade temperature of 99 was unknown and outcome of event coordination was off was recovering.   No follow-up attempts were possible, information about lot/batch number could not be obtained.
Sex: F
Vaccine: COVID19
Symptoms: General physical health deterioration, Infection, Investigation
Clinical narrative: she uses a walker so she is not real fast; Infection/low grade infection; slight elevation of white blood count; has a lot of health issues; The initial case was missing the following minimum criteria: Unspecified AE. Upon receipt of follow-up information on [10Aug2021], this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient) received via a female patient of an unspecified age received BNT162B2 (Lot Number: EN6200), via an unspecified route of administration on an unspecified date in 2021 as dose 1, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  It was reported that patient felt uncomfortable on receiving vaccine due to a rumor in her area that a schoolteacher received the Moderna vaccine and died. Patient stated that she is holding off on taking second dose of vaccine. she already received the first dose six months ago. On an unspecified date in 2021, last month she had lab work and it showed slight elevation of white blood count, indicating an infection, a low grade one, but it was not clarified, where the infection was. It was explained that she goes to the doctor all the time and has not had a fever at this point. But her lab work will not be repeated until in Oct2021. She wondered if she would get a recommendation on getting the vaccine while her lab work is showing the infection. She also had a lot of health issues and were related to side effects; well she feels like that every day, so she didn't want to make things worse, so, she missed the second dose, as she didn't want to take risk. She also reported that from an unspecified date, she uses a walker, so she was not real fast.The patient underwent lab tests and procedures which included, on an unspecified date in 2021, investigation: slight elevation of white blood count indicating low grade infection.  The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.  Follow-up (10Aug2021): New information from a contactable female consumer (patient) includes: the case was updated as valid, new events added.  Follow-Up (18Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: got a slight increase in body temperature of 101.1; This is a spontaneous report from a contactable consumer reported for a female patient (Wife).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration on 28Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patients concomitant medications were not reported. On an unknown date in 2021, patient got a slight increase in body temperature of 101.1 F. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lethargy, Pyrexia
Clinical narrative: Fever; chills; lethargy; This is a spontaneous report from a contactable consumer (patient). A 41-years-old female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9266, expiration date: May2021) via an unspecified route of administration in Arm Left on an unspecified date in 2021 (at the age of 41 years old) as dose 2, single for Covid-19 immunisation. Patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9262) via an unspecified route of administration in Arm Left on 23Jan2021 (at the age of 41 years old) as dose 1, single for Covid-19 immunisation and due to it patient experienced swollen left armpit, swollen left neck. The vaccination facility was hospital, was not administered at military facility, from prior vaccinations there were no adverse events. The adverse events did not require a visit to emergency room and physician office. On an unspecified date in 2021, the patient experienced Fever, Chills, Lethargy. No Relevant Tests reported. There are no predisposing factors and no culture performed. The outcome of all the events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: high fever; aches; sort throat; chills; tremors; and pains; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration on 16Feb2021 as single dose for covid-19 immunisation. Medical history included covid-19 from Oct2020 to an unknown date. The patient's concomitant medications were not reported. On unspecified date the patient experienced high fever, aches, sort throat, chills, tremors, and pains. 16Feb2021 was first dose of covid vaccine, she experienced the following side effects- sort throat, fever, aches and pains, chills, tremors. The second dose of covid vaccine is scheduled for 09Mar2021. She had a positive covid test in Oct2020. She heard from someone that if you had covid 19 in the past, you might not need to have the second dose of the vaccine. The patient underwent lab tests and procedures which included body temperature: high on unspecified date. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: high fever; aches; sort throat; chills; tremors; and pains; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration on 16Feb2021 as single dose for covid-19 immunisation. Medical history included covid-19 from Oct2020 to an unknown date. The patient's concomitant medications were not reported. On unspecified date the patient experienced high fever, aches, sort throat, chills, tremors, and pains. 16Feb2021 was first dose of covid vaccine, she experienced the following side effects- sort throat, fever, aches and pains, chills, tremors. The second dose of covid vaccine is scheduled for 09Mar2021. She had a positive covid test in Oct2020. She heard from someone that if you had covid 19 in the past, you might not need to have the second dose of the vaccine. The patient underwent lab tests and procedures which included body temperature: high on unspecified date. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Headache, Nausea
Clinical narrative: Back pain; Fever; chills; Headache; Nausea; Fatigue; This is a spontaneous report from a Non- Contactable consumer (patient). A 25-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration in left arm on 29Jan2021 at 08:30 (age at vaccination 25-year-old) as dose 1, single for Covid-19 immunization. The patient's medical history included Covid-19. Prior to vaccination, patient was diagnosed with COVID-19. Patient did not have any known allergies. The patient's concomitant medications were not reported. Patient did not receive any other vaccine in four weeks. Patient did not receive any other medications in two weeks. Patient did not test for Covid-19 post vaccination. Patient took Covid-19 vaccine in left arm on 23Feb2021 as dose 2 for Covid-19 immunization. On 29Jan2021 at 08:30 patient experienced fever, chills, back pain, headache, and nausea. Worst of it lasted 24 hours. headache, fatigue, and back pain persisted for 2- 3 days following. Patient did not receive any treatment for adverse events. The outcome of event was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Back pain; Fever; chills; Headache; Nausea; Fatigue; This is a spontaneous report from a Non- Contactable consumer (patient). A 25-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration in left arm on 29Jan2021 at 08:30 (age at vaccination 25-year-old) as dose 1, single for Covid-19 immunization. The patient's medical history included Covid-19. Prior to vaccination, patient was diagnosed with COVID-19. Patient did not have any known allergies. The patient's concomitant medications were not reported. Patient did not receive any other vaccine in four weeks. Patient did not receive any other medications in two weeks. Patient did not test for Covid-19 post vaccination. Patient took Covid-19 vaccine in left arm on 23Feb2021 as dose 2 for Covid-19 immunization. On 29Jan2021 at 08:30 patient experienced fever, chills, back pain, headache, and nausea. Worst of it lasted 24 hours. headache, fatigue, and back pain persisted for 2- 3 days following. Patient did not receive any treatment for adverse events. The outcome of event was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: elevated heart rate; This is a spontaneous report from a contactable female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number and Expiry date was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced elevated heart rate. The patient underwent lab tests and procedures which included heart rate: elevated on an unspecified date. Therapeutic measures were taken as a result of elevated heart rate with Benadryl. Inquiring if she should take the second vaccine. The clinical outcome of event was unknown.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Nasopharyngitis, Pyrexia, Vaccination site pain
Clinical narrative: Fever and cold; Injection Site Pain; Allergic Reactions; Fever and cold; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 19-year-old male patient received unspecified dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EN6198 and Expiry date was not reported), via an unspecified route of administration on 01Mar2021 (age at vaccination was 19-year-old) as dose number unknown, single for COVID-19 immunisation. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient concomitant medications were not reported. The patient did not receive other vaccine in four weeks. On 01Mar2021 at 21:00 patient experienced fever and cold, injection site pain (vaccination site pain) and allergic reactions. No treatment received for the events. Outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Palpitations
Clinical narrative: Numbness on left side of body - Face, arms and leg. The same side the vaccine was administered. Also included, Heart palpitations.; Heart palpitations; This is a spontaneous report from a non-contactable other healthcare professional.   A 30-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection), dose 2 intramuscular, administered in Arm Left on 11Feb2021 09:00 (Batch/Lot number and Expiry date was not reported) (at the age of 30-years-old) as DOSE 2, SINGLE for covid-19 immunization Public Health Clinic. The patient's other medical history was reported as none and no known allergies were reported. The patient concomitant medications were not reported. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) for covid-19 immunization. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine and no other medications in 2 weeks of covid-19 vaccine. The patient did not have covid prior to vaccination and has not been tested for covid since vaccination. On 11Feb2021 12:30 PM, the patient experienced numbness on left side of body-face, arms and leg. the same side the vaccine was administered. also included heart palpitations. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events was reported as recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia, Urinary tract infection
Clinical narrative: low grade fever; achiness; slight nausea; chills; UTI; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 71-years-old female patient (non-pregnant)received bnt162b2 (BNT162B2, Pfizer Covid-19 Vaccine, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 17Feb2021 15:15 (Batch/Lot Number: EN6200, Expiry date was not reported) (at the age of 71-years-old) as DOSE 2, SINGLE for covid-19 immunization. Medical history was not reported. Concomitant medications included losartan, pantoprazole, nitrofurantoin and vitamin D. Dosing regimen details, Start and stop dates of all concomitant medications were not reported. The patient previously received bnt162b2 (BNT162B2, Pfizer Covid-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm left on 27Jan2021 16:00 (Batch/Lot Number: EN5318, Expiry date was not reported) for covid-19 immunization. The patient did not have covid prior to vaccination and has not been tested for covid since vaccination. The patient did not receive any other vaccine within 4 weeks of covid vaccine. On 21Feb2021, the patient experienced urinary tract infection. On 07Mar2021, the patient experienced low grade fever, achiness, slight nausea and chills. It was reported that 1 day after second vaccination the patient experienced low grade fever, achiness, slight nausea, chills for one day ,18 days after second vaccination she again experienced the exact same symptoms for one day. The patient received antibiotics for urinary tract infection and did not receive any treatment for other events. The clinical outcome of urinary tract infection was unknown and other events was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 64-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), at the age of 64, via an unspecified route of administration, left arm, on Mar 5, 2021, 12:00, single dose, for COVID-19 immunisation. Medical history included obesity, prediabetes, heart rhythm dysfunction, COVID-19 (prior to vaccination) and slight penicillin allergy. Patient has not tested for COVID-19 post vaccination. Patient did not have other vaccine in four weeks. Concomitant medication included levothyroxine 75 mcg and vitamin D (ergocalciferol). On Mar 6, 2021, at 12:00, patient experienced fever 100.9ºF, chills, fatigue, soreness and heat near shot. The patient underwent lab tests and procedures, which included fever: 100.9ºF on Mar 6, 2021. Patient did not receive treatment for the adverse events. Outcome of the events resolved on an unspecified date in 2021. No follow-up attempts possible. No further information expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 64-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), at the age of 64, via an unspecified route of administration, left arm, on Mar 5, 2021, 12:00, single dose, for COVID-19 immunisation. Medical history included obesity, prediabetes, heart rhythm dysfunction, COVID-19 (prior to vaccination) and slight penicillin allergy. Patient has not tested for COVID-19 post vaccination. Patient did not have other vaccine in four weeks. Concomitant medication included levothyroxine 75 mcg and vitamin D (ergocalciferol). On Mar 6, 2021, at 12:00, patient experienced fever 100.9ºF, chills, fatigue, soreness and heat near shot. The patient underwent lab tests and procedures, which included fever: 100.9ºF on Mar 6, 2021. Patient did not receive treatment for the adverse events. Outcome of the events resolved on an unspecified date in 2021. No follow-up attempts possible. No further information expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever after receiving her second dose; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date (43-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a Dose 1, single for COVID-19 immunization. She stated that, she had been running a fever of 101.2 for a few hours and received the vaccine 26 hours ago. She also stated that she experienced a fever after her first dose, but it was "not that bad" and also reported "she had all the other symptoms that are listed in terms of headache, achiness, fatigue, and blah blah blah."  She was just concerned about the fever being this high and would like to know how long it was expected for this fever to last. She would like to know what medication she would recommend taking to help with the fever, as far as Ibuprofen or Tylenol. She would like to know if she should be concerned about running a fever after receiving her second dose of the Pfizer BioNTech COVID-19 vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Blood immunoglobulin G, Illness, Lymphadenopathy, Movement disorder, Pyrexia
Clinical narrative: fever; lymphadenopathy; couldn't move arm; got really sick; This is a spontaneous report from a contactable Physician. A 44 age (unit-unknown) male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 2 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of bnt162b2 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. After the second dose of the vaccine, the patient got really sick. He had a fever, lymphadenopathy, and couldn't move arm his arm. The reporter thought since he had this reaction he would have a high antibody level. The patient underwent lab tests and procedures which included blood immunoglobulin g: negative. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Had this Pfizer shot, I was lying down and realized that my heart started to do that same thing again and that reminded me of COVID; This is a spontaneous report from a contactable consumer (patient) or other non healthcare professional. A patient of unspecified age and gender received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced increased heart rate after having the first pfizer shot. The patient was lying down and realized that the heart started to do that same thing again and that reminded of covid on an unspecified date. The clinical course as follows, Consumer stated, "So, I received the first Pfizer shot vaccine on Monday, this 1st, so it's just a few days ago and I wanted to know I had a symptom in the evening that surprised me. So, I wanted to discuss it with you especially since you're a pharmacist because I wanted to know if it's common or uncommon or if it's something I should be concerned about. So, it's about the same. So, I had COVID a year ago, 19Mar was my first symptom." Consumer further stated, "So, I kind of knew, I had COVID and then I ended up having long term symptoms and it affected my heart as it does with other people. So, COVID affected my heart in a sense that I had these blurps and these out of control, not tachycardias but they were kind of like almost like an arrhythmia issue but not as tachycardia which is why it would like blurp and it lasted a long time on and off. And I actually went to a cardiologist and got a heart monitor to check it and they did verify and then it just kind of went away. And I did have one incident in the end of January and that was it, I've never experienced it again and my COVID symptoms lasted a long time but then they went away. And so, anyway I had this Pfizer shot on Monday and Monday night, I was lying down and just kind of watching a new show and I realized that my heart started to do that same thing again and that reminded me of COVID because that's what happened during COVID. It was like, it didn't seem like a coincident it lasted for about 2-3 minutes may be it was kind of a long time." The patient underwent lab tests and procedures which included increase in heart rate on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Injection site discomfort, Injection site inflammation, Pyrexia, Vaccination site erythema
Clinical narrative: mild fever of 100 degrees; red inflammation around the injection site stretching about two inches out that was super sensitive; red inflammation around the injection site stretching about two inches out that was super sensitive; red inflammation around the injection site stretching about two inches out that was super sensitive; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 24-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, Pfizer Covid-19 Vaccine, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 05Mar2021 08:45 (Batch/Lot number and Expiry date was not reported) (at the age of 24-years-old) as DOSE 2, SINGLE for covid-19 immunization. No other medical history was reported. There were no known allergies reported. Concomitant medications included birth control. The patient previously received bnt162b2 (BNT162B2, Pfizer Covid-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 12Feb2021 08:15 (Batch/Lot number and Expiry date was not reported) for covid-19 immunization. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. The patient did not have covid prior to vaccination and has not been tested for covid since vaccination. On 05Mar2021 17:30, the patient experienced mild fever of 100 degrees and red inflammation around the injection site stretching about two inches out that was super sensitive. It was reported that the patient had a mild fever of 100 degrees for a few hours after the dose and had red inflammation around the injection site stretching about two inches out that was super sensitive and is still present 72 hours later. Laboratory tests on 05Mar2021 included body temperature: 100 degrees. The patient did not receive any treatment for the reported events. The clinical outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease
Clinical narrative: congestion/COPD has a flair; This is a spontaneous report from a contactable consumer. A 85-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection and Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunisation. The historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection and Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the 2nd shot of Pfizer vaccine. On an unspecified date, the patient experienced congestion/COPD has a flair for every couple of events. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: headache; temperature at 100.5 degree F; This is a spontaneous report from a contactable consumer (patient). A 57-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection), dose 1 via an unspecified route of administration on 06Mar2021 (Lot Number: EN6206) as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Consumer stated, "I had the vaccine on Saturday, and I had a bad reaction to it. I had a 100-degree temperature for twenty-four hours (on 07Mar2021) and headache. The patient underwent lab tests and procedures which included body temperature: 100-degree temperature fahrenheit on unspecified date and body temperature: 100.5 fahrenheit on 07Mar2021. The outcome of events was Unknown.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: numbness to the left side of her cheek and the left side of her tongue; numbness to the left side of her cheek and the left side of her tongue; numbness to the left side of her cheek and the left side of her tongue / numbness migrated to my jaw / it made its way to my head / it was at the base of my head; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9269) via an unspecified route of administration, administered in Arm Right on 04Mar2021 (Age at Vaccination 58-years-old) as single dose for COVID-19 immunization. Medical history included none. Concomitant medications was not reported. Caller reports that she received her first Pfizer Covid injection last Thursday to her right arm. Caller reports that about a half hour later on 04Mar2021 she experienced numbness to the left side of her cheek and the left side of her tongue that lasted about 30 minutes to an hour. She reports that "the numbness migrated to my jaw "like if I got Novocain at the dentist" and it made its way to my head with numbness throughout my head which lasted to the next day. The next day when I woke up it was at the base of my head. Caller states she wanted to report a reaction and inquire about possible next steps. Caller states she received the Pfizer Covid vaccine on Thursday of last week, 04Mar2021, in her right arm, states about half and hour into it, she started getting numbness in her left cheek and left side of her tongue. States it lasted maybe an hour and a half, which the numbness then radiated down into her jaw and bottom of head and back of head, that lasted another day and a half. States the only way she can describe it is like when she goes to the dentist and they give Novocain. Caller was wondering what she should do next. The outcome of the events was recovered on 04Mar2021.  No follow up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Confusional state, Dizziness, Feeling abnormal, Heart rate increased
Clinical narrative: elevated heart rate; brain fog; anxiety; confusion; giddiness; This is a spontaneous report from a contactable consumer (Patient). A 40-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6203), dose 1 via an unspecified route of administration, administered in Arm Right on 28Feb2021 at 12:00 (at the age of 40 year) as dose 1, single for COVID-19 immunisation at Public Health Clinic/Veterans Administration facility. Medical history included asthma, beta thalassemia minor, tachycardia, partial lung collapse. Patient had known allergies codeine, penicillin. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. Concomitant medication(s) included vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), zinc (ZINC), vit d [vitamin d nos] (VIT D [VITAMIN D NOS]). On 28Feb2021 at 16:00, patient experienced elevated heart rate, brain fog, anxiety, confusion, giddiness. Patient did not receive any treatment. AE did not result in Physician office and emergency room. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling abnormal, Musculoskeletal stiffness, Pain, Pruritus
Clinical narrative: Fever; Her arm is red, hard, itchy; Her arm is red, hard, itchy; Her arm is red, hard, itchy; Side effects in her left arm/Can't touch it/it's sore to the touch; Feels like a bad bee sting; This is a spontaneous report from a contactable consumer or other non-health care professional reporting for herself. A female patient of age: 77 (unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 02Mar2021 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient had been experiencing fever and side effects in her left arm which included that the arm was red, hard, itchy and she could not touch it/it was sore to touch. The patient also added that it felt like a bad bee sting. The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Her arm is red, hard, itchy; Her arm is red, hard, itchy; Her arm is red, hard, itchy; Side effects in her left arm/Can't touch it/it's sore to the touch; Feels like a bad bee sting; This is a spontaneous report from a contactable consumer or other non-health care professional reporting for herself. A female patient of age: 77 (unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 02Mar2021 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient had been experiencing fever and side effects in her left arm which included that the arm was red, hard, itchy and she could not touch it/it was sore to touch. The patient also added that it felt like a bad bee sting. The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This is a spontaneous report from a contactable Physician via Pfizer sales representative. This Physician reported for a 27-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number : Not reported), via an unknown route of administration on an unknown date as dose 1, single for covid-19 immunisation. On an unspecified date, the patient experienced fever. It was reported that patient in the healthcare field received both Pfizer COVID 19 vaccine doses. Patient did not have any reaction after second dose. 1 month after second dose of the vaccine, patient experienced fever with no other symptoms for several days. Symptoms have since resolved but she wished to report the adverse symptoms in case they may be related to taking the vaccine. Event took place after use of product. The clinical outcome of event was recovered on unspecified date.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 100; This is a spontaneous report from a contactable consumer. This 67-year-old female consumer (patient) reported that she received bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number: unknown; Expiration date was not reported) via an unspecified route of administration on 02Mar2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization (age at vaccination:67-Years-old). The patient's medical history and concomitant medications were not reported. On 03Mar2021 the patient had fever of 100. It was reported that the patient had a fever of 100. was she supposed to take Tylenol. Reporter enquired that she wants to know if she can take Tylenol after receiving the COVID shot. The patient's laboratorial value included that the temperature was 100 after the receiving the bnt162b2. Temperature was 97-98 before the COVID Shot. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood pressure measurement, Burning sensation, Chest discomfort, Erythema
Clinical narrative: Experience warmth of left arm and chest; Warmth of left arm/ Left arm near injection site where warmth; Red rash present on left forearm; Tingling of left arm; Redness of lower and upper arm; BP; Swelling, burning or weakness of left arm; Swelling, burning or weakness of left arm; Swelling, burning or weakness of left arm; This is a spontaneous report from a non-contactable other HCP (the patient reported for self). A 36-years-old female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 mRNA Vaccine, Solution for injection, batch/lot number=EN6206), via an unknown route of administration in left arm on an unknown date as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that during her 15 minutes waiting period after the injection, the patient began to experience warmth of left arm and chest. Red rash present on left forearm. Later she developed tingling of left arm. She denied difficulty breathing, difficulty swallowing, light-headedness and dizziness. Redness of lower and upper arm. She still had some warmth of right arm after being observed for 1.5 hours. She did not have any rashes, swelling, burning or weakness of left arm. Discussed with patient continuing to ice left arm near injection site. If she experiences any redness, swelling, burning or worsening symptoms this weekend she was to seek medical care. Patient understands and agreed to plan. Patient was discharge and stable to go home and follow up with PCP. The patient received antihistamines, water, pepcid and Tylenol as treatment. Applied ice to left arm near injection site where warmth was noted. Follow up response to treatment was good. The outcome of the events was recovered upon discharge and BP improved; while the outcome of the event warmth of left arm/ Left arm near injection site where warmth and BP was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Paraesthesia, Peripheral swelling, Rash erythematous, Vaccination site warmth
Clinical narrative: Experience warmth of left arm and chest; Warmth of left arm/ Left arm near injection site where warmth; Red rash present on left forearm; Tingling of left arm; Redness of lower and upper arm; BP; Swelling, burning or weakness of left arm; Swelling, burning or weakness of left arm; Swelling, burning or weakness of left arm; This is a spontaneous report from a non-contactable other HCP (the patient reported for self). A 36-years-old female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 mRNA Vaccine, Solution for injection, batch/lot number=EN6206), via an unknown route of administration in left arm on an unknown date as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that during her 15 minutes waiting period after the injection, the patient began to experience warmth of left arm and chest. Red rash present on left forearm. Later she developed tingling of left arm. She denied difficulty breathing, difficulty swallowing, light-headedness and dizziness. Redness of lower and upper arm. She still had some warmth of right arm after being observed for 1.5 hours. She did not have any rashes, swelling, burning or weakness of left arm. Discussed with patient continuing to ice left arm near injection site. If she experiences any redness, swelling, burning or worsening symptoms this weekend she was to seek medical care. Patient understands and agreed to plan. Patient was discharge and stable to go home and follow up with PCP. The patient received antihistamines, water, pepcid and Tylenol as treatment. Applied ice to left arm near injection site where warmth was noted. Follow up response to treatment was good. The outcome of the events was recovered upon discharge and BP improved; while the outcome of the event warmth of left arm/ Left arm near injection site where warmth and BP was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Body temperature, Chills
Clinical narrative: 101 degree fever for four days. Fever exceeded 103 day two; joint pain; back pain; headache; chills; muscle pain; injection site pain; nausea; lethargy; swollen lymph nodes in breasts; swelling of face and eyes; swelling of face and eyes; dizziness; weakness; This is a spontaneous report from a contactable consumer (reported for herself). A 52-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EN6200/Batch was not reported), dose 1 via an unspecified route of administration, administered in arm left on 02Mar2021 at 11:45 (at the age of 52-years-old) as dose 1, single for covid-19 immunisation at Public Health Clinic/Administration facility. Medical history included congenital cystic kidney disease from an unknown date and unknown if ongoing and drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (LEVOTHYROXINE SODIUM), olmesartan (OLMESARTAN), zinc chloride (ZINC CHLORIDE), silicon dioxide (VIVISCAL [SILICON DIOXIDE]) and vitamin d nos (VITAMIN D NOS), all the drugs taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Mar2021 at 12:45, the patient experienced 101-degree fever for four days. fever exceeded 103 day two, joint pain, back pain, headache, chills, muscle pain, injection site pain, nausea, lethargy, swollen lymph nodes in breasts, swelling of face and eyes, dizziness and weakness. No treatment was given for the events. The patient underwent lab tests and procedures which included body temperature: 101 on 02Mar2021 (101-degree fever for four days) and body temperature: 103 on 04Mar2021 (Fever exceeded 103 day two). The outcome of the events was resolving.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.